Skip to main content

Table 6 Diagnostic performance of SNB for axillary staging in 18 F-FDG-positive and AUS-negative patients of category 2

From: Utility of 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in combination with ultrasonography for axillary staging in primary breast cancer

Patients

SUV

Involved SNs/resected SNs

Involved non-SNs/resected non-SNs

Ax dissection

1

8.1

1/1

0/10

Performed

2

2.5

1/1

0/17

Performed

3

2.4

1/2

0/12

Performed

4

1.4

1/3

0/21

performed

5

1.3

4/4

0/12

performed

6

0.7

1/4

0/6

performed

7

1.5

0/1

-

not performed

8

1

0/4

-

not performed

9

1

0/1

0/1

not performed

10

1

0/4

0/1

not performed

11

0.9

0/1

0/2

not performed

12

0.9

0/4

0/1

not performed

  1. AUS, Axillary ultrasound;SUV, Standardized uptake value; SNs, Sentinel nodes, Ax, Axillary